Geistlich Pharma AG: New Geistlich Pharma AG company profile published
Geistlich Pharma AG (Geistlich) provides medical devices to the healthcare market. It is a part of Geistlich Group. The company specializes in biomedicine, dental, orthopaedics, sports medicine and traditional drugs. Geistlich operates through three business units, namely, Geistlich Biomaterials, Geistlich Surgery and Geistlich Medical. Its product portfolio includes biological bone and cartilage regeneration products, dental regenerative products, pharmaceuticals and hydrogels, among others. It operates through subsidiaries and affiliates in Germany, China, France, Italy, the UK, Ireland, Brazil, the US and South Korea. Geistlich is headquartered in Wolhusen, Switzerland.
Geistlich Pharma AG Key Recent Developments
Feb 02, 2012: Geistlich Pharma Establishes New Affiliate In North America
Geistlich Pharma AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company's operations and business divisions.
- Corporate strategy – Our summarization of the company's business strategy.
- SWOT analysis – A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives' employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
Note: Some sections may be missing if data is unavailable for the company.
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors' business structure and strategies with our detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Geistlich Pharma AG - Key Facts
Geistlich Pharma AG - Key Employees
Geistlich Pharma AG - Key Employee Biographies
Geistlich Pharma AG - Key Operational Employees
Geistlich Pharma AG - Major Products and Services
Geistlich Pharma AG - History
Geistlich Pharma AG - Company Statement
Geistlich Pharma AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Section 2 – Company Analysis
Geistlich Pharma AG - Business Description
Geistlich Pharma AG - SWOT Analysis
SWOT Analysis - Overview
Geistlich Pharma AG - Strengths
Strength - Market Reach
Strength - Product Portfolio
Geistlich Pharma AG - Weaknesses
Weakness - Lack of Transparency
Geistlich Pharma AG - Opportunities
Opportunity - Rising Healthcare Expenditure
Opportunity - Growth Potential: Dental Biomaterials Market
Geistlich Pharma AG - Threats
Threat - Stringent Regulations
Threat - Uncertain R&D Outcomes
Threat - Competitive Landscape
Geistlich Pharma AG - Key Competitors
Section 3 – Company's Lifesciences Financial Deals and Alliances
Geistlich Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Geistlich Pharma AG, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
Geistlich Pharma AG, Recent Deals Summary
Section 4 – Company's Recent Developments
Geistlich Pharma AG, Recent Developments
15/06/2012: Geistlich Showcases Geistlich Bio-Oss Pen At 7th Europerio
14/02/2012: Geistlich's Chondro-Gide Reimbursed In Australia
02/02/2012: Geistlich Pharma Establishes New Affiliate In North America
20/12/2011: Geistlich Obtains Market Authorisation For Bio-Oss Bone Substitute Material In Japan
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Geistlich Pharma AG, Key Facts
Geistlich Pharma AG, Key Employees
Geistlich Pharma AG, Key Employee Biographies
Geistlich Pharma AG, Key Operational Employees
Geistlich Pharma AG, Major Products and Services
Geistlich Pharma AG, History
Geistlich Pharma AG, Other Locations
Geistlich Pharma AG, Subsidiaries
Geistlich Pharma AG, Affiliate
Geistlich Pharma AG, Key Competitors
Geistlich Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Geistlich Pharma AG, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
Geistlich Pharma AG, Recent Deals Summary
List of Tables
Geistlich Pharma AG, Key Facts
Geistlich Pharma AG, Key Employees
Geistlich Pharma AG, Key Employee Biographies
Geistlich Pharma AG, Key Operational Employees
Geistlich Pharma AG, Major Products and Services
Geistlich Pharma AG, History
Geistlich Pharma AG, Other Locations
Geistlich Pharma AG, Subsidiaries
Geistlich Pharma AG, Affiliate
Geistlich Pharma AG, Key Competitors
Geistlich Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Geistlich Pharma AG, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
Geistlich Pharma AG, Recent Deals Summary 20